A Smarter Approach to Cell Line Development

In cell line development (CLD), every step – from single-cell isolation to imaging and early process optimisation – requires precision. Earlier this year, we explored the importance of specialist imaging in CLD workflows with SYNENTEC, and why dedicated technologies lead to more consistent, higher-quality data (read the article here: https://bioprocess-eng.co.uk/news-insights/routine-cld-to-advanced-assays/). Since then, we’ve expanded our portfolio at BPES to further strengthen that philosophy: using specialist technologies at each stage, supported by focused expertise, rather than relying on a single, generalised system.

All-in-one platforms aim to simplify workflows, but in practice, they introduce compromise. In CLD, where data quality and reproducibility are critical, that compromise can limit outcomes.

Our approach is different. We combine best-in-class instruments, each designed to excel in its specific role – backed by specialist support to keep workflows running efficiently, and capable of being integrated into automated platforms to enable streamlined, hands-off operation where required.

Precision at the Start: Single-Cell Isolation with DispenCell-S4

The DispenCell-S4 from SEED Biosciences addresses one of the most critical steps in CLD: establishing monoclonality.

What differentiates this system from “all-in-one” alternatives is its underlying technology and focus. Using impedance-based detection, it identifies and dispenses individual cells with high precision while recording a traceable signal for each event. This provides immediate, documented evidence of monoclonality, aligning with regulatory expectations for cell line development.

The system is also designed for gentle handling, operating at very low pressure to preserve cell viability – critical for successful clone outgrowth.

From a workflow perspective, this level of specialisation delivers clear advantages:

• Reduces reliance on probabilistic methods, such as limiting dilution
• Enables single-step cloning workflows, improving efficiency and timelines
• Provides traceable, audit-ready data to support regulatory submissions

While the DispenCell-S4 delivers a high probability of monoclonality, this can be strengthened further through complementary verification. Using dedicated imaging systems from SYNENTEC provides visual confirmation and longitudinal tracking of clonal outgrowth, increasing overall confidence.

Rather than being one feature within a broader system, the DispenCell-S4 is engineered specifically for this challenge – while integrating seamlessly into a wider CLD workflow.

Specialist Imaging for CLD: Expertise with SYNENTEC

As highlighted in our earlier article, imaging is a core part of CLD – not a secondary feature. This is where specialists like SYNENTEC add real value, rather than relying on built-in imaging within all-in-one systems.

SYNENTEC’s automated imaging systems – CELLAVISTA and NYONE – are designed specifically for cell-based workflows, supporting everything from routine CLD tasks such as confluency and cloning through to more advanced applications, including integration into automated environments where higher throughput and hands-off operation are required.

From a workflow perspective, this specialist focus delivers clear advantages:

• Ensures high-quality, reproducible imaging data across CLD stages
• Supports both routine monitoring and more advanced assay development
• Provides biologically relevant insights, not just images
• Gives access to dedicated imaging expertise and validated methods

For customers, this means greater confidence in imaging data and more reliable decision-making – something often limited in all-in-one platforms.

Scalable Process Development: Leadgene Biosolutions Microbioreactors

As CLD progresses towards process optimisation, microbioreactor systems from Leadgene Biosolutions – C.BIRD, C.NEST 2.0, and S.NEST 2.0 – provide a level of process insight typically not achievable with all-in-one systems.

A key differentiator is their micro-scale bioreactor design with controlled mixing, which more closely mimics larger-scale conditions than static culture. This improves nutrient distribution and oxygen transfer, supporting more consistent and reproducible cell growth.

These systems address a common gap in CLD: generating process-relevant data early. By enabling high-throughput, parallel experiments in standard multi-well formats, they allow researchers to:

• Evaluate multiple clones, media, and conditions simultaneously
• Generate more predictive data for scale-up
• Improve confidence in early-stage decisions

Designed to bridge early research and biomanufacturing, these platforms support a smoother transition into process optimisation, with features such as real-time pH and dissolved oxygen monitoring enhancing process understanding.

Why This Matters

For teams working in biotech, biopharma, and cell & gene therapy, CLD is a series of interdependent steps where small improvements at each stage can have a significant downstream impact. A specialist approach increases confidence in monoclonality, aligns imaging with workflow needs, and enables earlier generation of process-relevant data.

Just as importantly, it provides access to dedicated, application-focused support. When issues arise, working with specialist providers means they can be identified and resolved more quickly – minimising disruption and keeping projects on track.

In practice, this supports better decision-making at every stage—whether identifying viable clones, monitoring cell behaviour, or optimising culture conditions using data that reflects real bioprocess environments. The result is reduced risk, improved reproducibility, and more efficient progression from development through to scale-up.

A Practical Alternative to “All-in-One”

All-in-one solutions offer convenience, but in CLD, convenience often comes at the cost of precision, flexibility, and data quality.

By contrast, our expanded CLD portfolio – featuring the DispenCell-S4, CELLAVISTA / NYONE, and C.BIRD / C.NEST 2.0 / S.NEST 2.0 – reflects a more practical approach: using specialist tools to solve specific challenges, supported by expert partners who can respond quickly when it matters, while still enabling integration into automated workflows.

For organisations focused on quality, scalability, and long-term success in cell line development, that difference matters.